Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CMTM6 shapes antitumor T cell response through modulating protein expression of CD58 and PD-L1
Beiping Miao, Zhaoqing Hu, Riccardo Mezzadra, et al.
Cancer Cell (2023) Vol. 41, Iss. 10, pp. 1817-1828.e9
Open Access | Times Cited: 22

Showing 22 citing articles:

Impact of KRAS mutation on the tumor microenvironment in colorectal cancer
Yiru Zhou, Yeye Kuang, Chan Wang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 5, pp. 1947-1964
Open Access | Times Cited: 9
Evaluation of the effect of GSK-3β on liver cancer based on the PI3K/AKT pathway
Jiageng Guo, Xinya Jiang, Jing Lian, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5
Phase separation of chimeric antigen receptor promotes immunological synapse maturation and persistent cytotoxicity
Xinyi Xu, Haotian Chen, Z. Z. Ren, et al.
Immunity (2024)
Closed Access | Times Cited: 4
CMTM4 promotes the motility of colon cancer cells under radiation and is associated with an unfavorable neoadjuvant chemoradiotherapy response and patient survival in rectal cancer
Lujing Yang, Z. Miao, Ningning Li, et al.
Oncology Letters (2025) Vol. 29, Iss. 3
Open Access
The Significance of Cellular Senescence Hub Genes in the Diagnosis and Subtype Classification of a Comprehensive Database of Gene Expression in Intervertebral Disc Degeneration
Fei Liu, Silong Gao, Yin Ji, et al.
JOR Spine (2025) Vol. 8, Iss. 1
Open Access
Comprehensive analysis of CMTM family and immune infiltration in esophageal carcinoma
Liying Xue, Shengsong Gou, Yu Zhang, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0321037-e0321037
Open Access
A potential prognostic marker for hematologic neoplasms: CD58
Jiajia Cao, Yurong Zhang, Ningning Yue, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2
Yunju Jo, Hye-In Sim, B.‐S. YUN, et al.
Experimental & Molecular Medicine (2024)
Open Access | Times Cited: 3
From patient tissue correlates to molecular mechanisms of cancer immune evasion: the emerging role of CD58 and PD-L1 co-regulation via CMTM6
Johannes C. Melms, Patricia Ho, Meri Rogava, et al.
Genes and Immunity (2023) Vol. 25, Iss. 1, pp. 82-84
Closed Access | Times Cited: 4
Clinical significance of immune-related antigen CD58 in gliomas and analysis of its potential core related gene clusters
Zhi Gang Tian, Wei Jia, Zhao Wang, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29275-e29275
Open Access | Times Cited: 1
Impact of high-salt diet in health and diseases and its role in pursuit of cancer immunotherapy by modulating gut microbiome
Yuvaraj Balan, Raja Sundaramurthy, Archana Gaur, et al.
Journal of Family Medicine and Primary Care (2024) Vol. 13, Iss. 5, pp. 1628-1635
Open Access | Times Cited: 1
CMTM6 maintains B cell-intrinsic CD40 expression to regulate anti-tumor immunity
Yiru Long, Runqiu Chen, Wenlong Chang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
CMTM6 overexpresses in ovarian cancer and associated with tumor cell progression and stabilization of PD-L1 protein
Jing Qian, Xia Zhang, Jinyi Tong, et al.
Research Square (Research Square) (2024)
Open Access
The Atlantic Cod MHC I compartment has the properties needed for cross-presentation in the absence of MHC II
Synne Arstad Bjørnestad, Monica Hongrø Solbakken, Paal Krokene, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Current advancements in PD-L1 modulation by CMTM6 in malignant tumors
Lisha Zhang, Sisi He, Lixing Wu, et al.
ONCOLOGIE (2024)
Open Access
Ni‐MOF Engineered System Targeting Macrophage Aurora A Kinase for Bone Loss Prevention Through PD‐L1 Activation
Wenqian Zhang, Shengming Zhang, Minghao He, et al.
Advanced Functional Materials (2024)
Open Access
Preclinical in vitro models of HNSCC and their role in drug discovery - an emphasis on the cancer microenvironment and microbiota
Anne‐Sophie Becker, Sonja Oehmcke-Hecht, Erik Dargel, et al.
Expert Opinion on Drug Discovery (2024), pp. 1-21
Open Access
CMTM6 promotes hepatocellular carcinoma invasion and metastasis and tumor-associated neutrophil immunoinfiltration through the Wnt/β-catenin pathway
Panpan Kong, Huan Yang, Huifang Liu, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access
Overcoming radiation-induced PD-L1 upregulation by novel gadolinium-palladium nanoplatforms for enhanced tumor radio-immunotherapy
Kai Guo, Hui Liu, Mengmeng Zhang, et al.
Chemical Engineering Journal (2024), pp. 158754-158754
Closed Access
Cancer immunotherapeutic challenges from autophagy-immune checkpoint reciprocal regulation
Gang Zhang, Yinfeng Chen, Xing Huang, et al.
Trends in cancer (2024)
Closed Access
PD-L1 and CD58 co-regulated by CMTM6 play yin and yang to shape anti-tumor immunity
Hirohito Yamaguchi, Mien‐Chie Hung
Cancer Cell (2023) Vol. 41, Iss. 10, pp. 1701-1704
Open Access
Cmtm6 Promotes Hepatocellular Carcinoma Invasion and Metastasis and Tumor-Associated Neutrophil Immunoinfiltration Through the Wnt/Β-Catenin Signaling Pathway
Panpan Kong, Huan Yang, Huifang Liu, et al.
(2023)
Closed Access
Protein auf Tumorzellen fördert Immunreaktion gegen Krebs

TumorDiagnostik & Therapie (2023) Vol. 44, Iss. 09, pp. 596-596
Closed Access
Page 1

Scroll to top